Octave Specialty director granted 7,441 RSUs

IGLESIAS LISA G reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

IGLESIAS LISA G reported acquisition or exercise transactions in this Form 4 filing.

Octave Specialty Group director Lisa G. Iglesias received a grant of 7,441 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the company’s common stock. Following this award, her directly held equity-linked interest totals 16,091 shares.

The RSUs were granted on April 1, 2026 and are scheduled to vest one year later on April 1, 2027. Vested RSUs will settle into common shares on the vesting date or when she ceases to serve on the Board of Directors, unless she elects to defer settlement.

Insider Trade Summary

Grant/Award: 7,441 shares

Grant/Award 1 txn

Insider IGLESIAS LISA G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	7,441	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 16,091 contracts (Direct)

Footnotes (2)

F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Octave Specialty Group, Inc. (the "Company").
F2. RSU's granted on April 1, 2026 shall vest one year later on April 1, 2027. RSUs that have become vested shall settle and convert into shares of common stock upon the earlier of the vesting date or the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company, unless otherwise deferred upon the election of the Reporting person.

Key Figures

RSUs granted: 7,441 units Shares per RSU: 1 share Total holdings after grant: 16,091 shares +1 more

4 metrics

RSUs granted 7,441 units Restricted stock units granted on April 1, 2026

Shares per RSU 1 share Each RSU represents one share of common stock

Total holdings after grant 16,091 shares Equity-linked interest following the RSU award

Vesting date April 1, 2027 Scheduled vesting for RSUs granted April 1, 2026

Key Terms

Restricted Stock Units, RSU, vest, Board of Directors

4 terms

Restricted Stock Units financial

"The filing reports a grant of 7,441 Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

vest financial

"RSU's granted on April 1, 2026 shall vest one year later on April 1, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Board of Directors financial

"the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors"

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Octave Specialty Group (OSG) disclose about director Lisa G. Iglesias?

Octave Specialty Group disclosed that director Lisa G. Iglesias received a grant of 7,441 restricted stock units. These RSUs give her a contingent right to receive the company’s common shares, increasing her total directly held equity-linked interest to 16,091 shares after the award.

How many restricted stock units did the OSG director receive in this Form 4?

Lisa G. Iglesias received 7,441 restricted stock units in this reported transaction. Each unit represents a right to one share of Octave Specialty Group common stock, subject to vesting and settlement conditions described in the footnotes to the filing.

When do the newly granted OSG restricted stock units vest?

The restricted stock units granted on April 1, 2026 are scheduled to vest on April 1, 2027. This one-year vesting period applies to the entire 7,441-unit grant, subject to her continued service on Octave Specialty Group’s Board of Directors.

What happens when the OSG restricted stock units held by Lisa G. Iglesias vest?

Once vested, each restricted stock unit converts into one share of Octave Specialty Group common stock. Settlement occurs on the vesting date or when she ceases to be a board member, unless she elects to defer settlement under the company’s applicable arrangements.

How many Octave Specialty Group shares does Lisa G. Iglesias hold after this RSU grant?

After the RSU grant, Lisa G. Iglesias has a total equity-linked interest of 16,091 shares. This figure reflects her holdings following the award of 7,441 restricted stock units as reported in the Form 4 filing for Octave Specialty Group.

What type of transaction is reported in this OSG Form 4 filing?

The filing reports an acquisition of derivative securities classified as restricted stock units. The transaction code is “A,” indicating a grant or award, and it is not an open-market purchase or sale of Octave Specialty Group common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/02/2026 - 04:38 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

IGLESIAS LISA G

(Last)

(First)

(Middle)

C/O OCTAVE SPECIALTY GROUP, INC.

40 WALL STREET, 55TH FLOOR

(Street)

NEW YORK

10005

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OCTAVE SPECIALTY GROUP INC [ OSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	04/01/2026		A		7,441		⁽²⁾	⁽²⁾	Common Stock	7,441	$0	16,091	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Octave Specialty Group, Inc. (the "Company").

2. RSU's granted on April 1, 2026 shall vest one year later on April 1, 2027. RSUs that have become vested shall settle and convert into shares of common stock upon the earlier of the vesting date or the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company, unless otherwise deferred upon the election of the Reporting person.

Remarks:

	William White, attorney-in-fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR